Abstract:Background Enzyme matrix metalloproteinase-9 is a member of the matrix metalloproteinase family, which is critical to normal tissue remodelling during embryogenesis and wound healing. In patients with endometriosis, increased expression and activity of matrix metalloproteinase-9 have been observed in ectopic endometrium, but the plasma and peritoneal fluid concentrations of matrix metalloproteinase-9 in patients with endometriosis and their relation to disease severity have not been clear. The aim of the study was to investigate the concentrations of matrix metalloproteinase-9 in plasma and peritoneal fluid of patients with endometriosis.Methods A prospective case-control study was conducted in Jinan Military General Hospital between January 2010 and December 2013. Fifty patients with proven endometriosis and 26 endometriosis-free controls were enrolled in this study. Patients with endometriosis were evaluated and divided into moderate/severe endometriosis group (stage I-II, n=26) and minimal/mild endometriosis group (stage III-IV, n=24) according to the revised criteria of the American Society for Reproductive Medicine. Blood samples and peritoneal fluid were obtained from both patients and controls. Matrix metalloproteinase-9 was measured using enzyme-linked immunosorbent assay in plasma and peritoneal fluid. The concentration of matrix metalloproteinase-9 between different groups was compared and its correlation to disease severity was analysed.Results Plasma and peritoneal fluid concentrations of matrix metalloproteinase-9 in patients with endometriosis were higher than that in controls. In addition, those patients with moderate/severe endometriosis had significantly higher plasma and peritoneal fluid concentrations of matrix metalloproteinase-9 compared to those with minimal/mild endometriosis. Matrix metalloproteinase-9 concentrations in plasma and peritoneal fluid were both positively correlated with severity of endometriosis and plasma matrix metalloproteinase-9 concentrations had a positive correlation with peritoneal fluid matrix metalloproteinase-9 concentrations in patients with endometriosis.Conclusions Increased concentrations of plasma and peritoneal fluid concentrations of matrix metalloproteinase-9 appear to be associated with disease severity of endometriosis and may serve as an alternative biomarker to determine disease severity of endometriosis.

Correlation Between Matrix Metalloproteinase-9 and Endometriosis

Correlation of Polypeptide N-Acetylgalactosamine Transferases-3 And-6 to Different Stages of Endometriosis

Research on the Expression of KISS-I/MMP-9 in Ectopic and Eutopic Endometrium from Women with Endometriosis and Its Biological Significances

Overexpressed Mps-1 Contributes To Endometrioma Development Through The Nf-Kappa B Signaling Pathway

Increased expression of c-fos protein associated with increased matrix metalloproteinase-9 protein expression in the endometrium of endometriotic patients.

Matrix metalloproteinase 2 is associated with changes in steroid hormones in the sera and peritoneal fluid of patients with endometriosis.

Overexpressed MPS-1 contributes to endometrioma development through the NF-κB signaling pathway

The Plasma and Peritoneal Fluid Concentrations of Matrix Metalloproteinase-9 Are Elevated in Patients with Endometriosis

Pgpm_a_354957 377..392

[Expression of Matrix Metalloproteinases-9 and Tissue Inhibitor of Metalloproteinases-1 Mrna in the Endometrium During Mid- Luteal Phase in Women with Unexplained Infertility].

[Expressions of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Ectopic and Eutopic Endometrium].

Detection of MMP-2,9 activity in sera and peritoneal fluid in women with endometriosis and its clinical significance

Expression and Significance of MMP-9 and TIMP-1 in Endometriosis

Expression of Survivin and MMP-9 in Eutopic Endometrium of Patients with Endometriosis

Expression of MMP9,TIMP1,VEGF in Ectopic and Eutopic Endometrium in Patients with Endometriosis

Expression of MMPs/TIMP in Endometriosis

Serum HSF1 is upregulated in endometriosis patients and serves as a potential diagnostic biomarker

Exploring Epithelial–Mesenchymal Transition Signals in Endometriosis Diagnosis and In Vitro Fertilization Outcomes

The expression and clinical significance of matrix metalloproteinase inhibitor-RECK in endometriosis

Clinical significance of MMP-9 overexpression in endometrial cancer: A PRISMA-compliant meta-analysis

Study on the correlation between endometriosis and adverse pregnancy outcomes